Testing a new eye drop for eyelid inflammation caused by tiny mites
Part of Eyes & vision clinical trials.
This trial tests an investigational eye drop (GLK-321) to see if it safely and effectively treats Demodex blepharitis, an eyelid inflammation caused by tiny mites. It may help people who have signs of this condition and good enough vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have signs of Demodex blepharitis in at least one eye
- Your vision is 20/80 or better in each eye (with glasses if needed)
- You do not have eczema or dermatitis on or around your eyes
- You have not used any eyelid hygiene products in the past 14 days
- You do not have an active eye infection or inflammation (other than blepharitis)
- You are not pregnant, planning pregnancy, or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicated eye drop (lotilaner) to treat eyelid mite inflammation (Demodex blepharitis) in people who wear PROSE scleral lenses. It aims to see if the drops safely reduce symptoms like redness, itching, and blurry vision.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
This study tests an eye drop called GLK-221 for people with keratoconus, a condition where the clear front of the eye bulges. The goal is to see if the drops can safely help improve the condition compared to a placebo (an inactive solution).
This study tests a new lubricating eye drop designed to relieve dry eye symptoms. If you have dry eye disease, this trial may help determine if the new formula works better than what's currently available.
This trial tests the SUMMIT BRUSH to see if it helps treat blepharitis, an eyelid problem that can be linked to bacteria or tiny mites. It checks whether using the brush improves eyelid signs and symptoms in people who have specific visible findings on exam.
Hear when a new Demodex Blepharitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.